Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
about
Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lungA decade of Burkholderia cenocepacia virulence determinant researchIn vitro susceptibility of Burkholderia vietnamiensis to aminoglycosidesMechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial CellsThe multifarious, multireplicon Burkholderia cepacia complexTaxonomy and pathogenesis of the Burkholderia cepacia complexCable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium.Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.Detection of cultured and uncultured Burkholderia cepacia complex bacteria naturally occurring in the maize rhizosphere.Identification of genes regulated by the cepIR quorum-sensing system in Burkholderia cenocepacia by high-throughput screening of a random promoter library.Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry.Propionibacterium acnes types I and II represent phylogenetically distinct groups.Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients.The changing microbial epidemiology in cystic fibrosis.Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.In vivo fluorescence imaging of bacteriogenic cyanide in the lungs of live mice infected with cystic fibrosis pathogens.Fosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolatesTransmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages.Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouseDiversity and significance of Burkholderia species occupying diverse ecological niches.Infection control in cystic fibrosis.Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia)Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1.Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence.Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis CNasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepaciaMolecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study.Isolation of infectious cystic fibrosis patients: results of a systematic review.The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepaciaMultidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Iron acquisition mechanisms of the Burkholderia cepacia complex.Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patientsTwo outbreaks of Burkholderia cepacia nosocomial infection in a neonatal intensive care unit.Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
P2860
Q24561589-A12A6D2E-3E55-4B75-9F22-3C826B76BD55Q24594813-D33E2D5A-C27A-479D-B426-FCE07A3D4663Q24599890-5C174D65-69A0-4B17-B4CD-32F92D3B6A6FQ26774483-D9976622-5617-4EBA-B2A7-5A49EBA244C0Q28301994-6C6B23AA-6D2A-4CFD-A3CF-0E4E1C44284CQ28302423-3AB1B438-AF77-480C-9D2C-8AE62946C060Q30437827-A7952F04-B6C8-4C04-A3D3-787B3B8AA7ACQ30448548-2298C944-4E6E-435F-BD44-44462D2D0EF0Q33219966-CBFCB8CE-CB23-4BA0-89CD-9BF001E6099BQ33225424-C6C72AA6-D1A0-4310-AFFA-2C772AE08891Q33264441-DA3AC9AD-2057-4745-A218-081B5BB0AAA0Q33323078-0C954E09-8264-493E-8235-D3CF43D84BDDQ33454687-5DAED137-5F98-4E23-8FE4-314EC96BD1B1Q33592477-52F605F4-5250-4577-9458-4B935DAB09D8Q33771827-F945909B-5874-45DD-8D58-6DC3E0EF1992Q33825634-F6543436-7426-48DF-B2B9-46458809F191Q33856422-2FA2B5F6-4422-4948-92B7-1D5606BDDDC7Q33959291-40B8E93E-6FC3-4428-9353-B0EA72939140Q34057514-EFED0513-149A-4D6C-9C9B-ACF9E6113555Q34073326-43951F3B-E908-4789-B4D3-44AB2AC86A26Q34155441-06E9A80F-D3F4-4332-BC05-62E78BA82C3DQ34581543-392ECCBF-1C17-47A2-9CF2-EF8E06D787BAQ35200150-2975F6B7-88AE-4CE2-83DA-8710D3E09FAAQ35545544-658F0604-F461-43D1-A1C3-23EB2A848AC3Q35632107-B3C88F77-B1E6-4329-8212-A7910049BC5AQ35685398-37949F4F-3286-4B00-A6FA-73925F9252C0Q35764624-865431EF-B3AA-4325-9CDC-DBEE059DFE94Q35801951-8F23C296-EDB7-47F6-A264-55597A6CEF25Q35895940-BD05A721-681E-4BB9-B00D-B37659E676D9Q35913531-C389F84B-D98C-4B1A-A570-CCB00C01A682Q35922213-51195450-4CC9-49FE-B6C6-758F19D2B529Q36112367-CAC0D70C-B4BE-4471-AEBC-6D32E33EE081Q36576278-D0B2A6E2-F5EC-48CE-BE7D-A1C7B1E8211CQ36670892-A810B770-36BC-49CC-A166-C12E6D2D17D3Q36733887-6E0017C8-E492-4E90-814D-DE0B26705FA5Q36845344-1BBD80A2-F5C8-46BC-8CD8-4A27029832B2Q36886322-9EE1EF39-B0A7-4A13-B7B1-B9EBB30FF1D5Q36895659-0F2D000C-5CCB-4D21-8D24-018CE45631CDQ37033480-EB56AA1A-E2FF-4E13-B06C-32852E68D94BQ37064461-05A8815B-CA09-4616-B7C0-9AE781B7EF41
P2860
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@ast
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@en
type
label
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@ast
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@en
prefLabel
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@ast
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@en
P2093
P2860
P921
P356
P1476
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada
@en
P2093
David P Speert
Deborah Henry
Eshwar Mahenthiralingam
Mary Corey
Peter Vandamme
P2860
P304
P356
10.3201/EID0802.010163
P577
2002-02-01T00:00:00Z